Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Sci ; 123(Pt 4): 595-605, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-20103534

ABSTRACT

Cholesterol and sphingolipids are abundant in neuronal membranes, where they help the organisation of the membrane microdomains involved in major roles such as axonal and dendritic growth, and synapse and spine stability. The aim of this study was to analyse their roles in presynaptic physiology. We first confirmed the presence of proteins of the exocytic machinery (SNARES and Ca(v)2.1 channels) in the lipid microdomains of cultured neurons, and then incubated the neurons with fumonisin B (an inhibitor of sphingolipid synthesis), or with mevastatin or zaragozic acid (two compounds that affect the synthesis of cholesterol by inhibiting HMG-CoA reductase or squalene synthase). The results demonstrate that fumonisin B and zaragozic acid efficiently decrease sphingolipid and cholesterol levels without greatly affecting the viability of neurons or the expression of synaptic proteins. Electron microscopy showed that the morphology and number of synaptic vesicles in the presynaptic boutons of cholesterol-depleted neurons were similar to those observed in control neurons. Zaragozic acid (but not fumonisin B) treatment impaired synaptic vesicle uptake of the lipophilic dye FM1-43 and an antibody directed against the luminal epitope of synaptotagmin-1, effects that depended on the reduction in cholesterol because they were reversed by cholesterol reloading. The time-lapse confocal imaging of neurons transfected with ecliptic SynaptopHluorin showed that cholesterol depletion affects the post-depolarisation increase in fluorescence intensity. Taken together, these findings show that reduced cholesterol levels impair synaptic vesicle exocytosis in cultured neurons.


Subject(s)
Cholesterol/metabolism , Exocytosis/physiology , Synaptic Vesicles/physiology , Animals , Anticholesteremic Agents/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Calcium Channels, N-Type/metabolism , Cells, Cultured , Exocytosis/drug effects , Fumonisins/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Immunoglobulin G/metabolism , Lovastatin/analogs & derivatives , Lovastatin/pharmacology , Membrane Microdomains/metabolism , Microscopy, Electron, Transmission , Models, Neurological , Neurons/drug effects , Neurons/physiology , Neurons/ultrastructure , Presynaptic Terminals/drug effects , Presynaptic Terminals/physiology , Presynaptic Terminals/ultrastructure , Rats , SNARE Proteins/metabolism , Sphingolipids/metabolism , Synaptic Vesicles/drug effects , Synaptic Vesicles/ultrastructure , Synaptotagmin I/antagonists & inhibitors , Synaptotagmin I/immunology , Synaptotagmin I/metabolism , Tricarboxylic Acids/pharmacology
2.
J Neurochem ; 100(3): 664-77, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17144906

ABSTRACT

A number of proteins and signalling molecules modulate voltage-gated calcium channel activity and neurosecretion. As recent findings have indicated the presence of Ca(v)2.1 (P/Q-type) channels and soluble N-ethyl-maleimide-sensitive fusion protein attachment protein receptors (SNAREs) in the cholesterol-enriched microdomains of neuroendocrine and neuronal cells, we investigated whether molecules known to modulate neurosecretion, such as the heterotrimeric G proteins and neuronal calcium sensor-1 (NCS-1), are also localized in these microdomains. After immuno-isolation, flotation gradients from Triton X-100-treated synaptosomal membranes revealed the presence of different detergent-resistant membranes (DRMs) containing proteins of the exocytic machinery (Ca(v)2.1 channels and SNAREs) or NCS-1; both DRM subtypes contained aliquots of heterotrimeric G protein subunits and phosphatidylinositol-4,5-bisphosphate. In line with the biochemical data, confocal imaging of immunolabelled membrane sheets revealed the localization of SNARE proteins and NCS-1 in different dot-like structures. This distribution was largely impaired by treatment with methyl-beta-cyclodextrin, thus suggesting the localization of all three proteins in cholesterol-dependent domains. Finally, bradykinin (which is known to activate the NCS-1 pathway) caused a significant increase in NCS-1 in the DRMs. These findings suggest that different membrane microdomains are involved in the spatial organization of the complex molecular network that converges on calcium channels and the secretory machinery.


Subject(s)
Membrane Microdomains/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neurosecretion/physiology , Neurosecretory Systems/metabolism , Synaptic Membranes/metabolism , Animals , Bradykinin/pharmacology , Calcium Channels, N-Type/metabolism , Exocytosis/drug effects , Exocytosis/physiology , Membrane Microdomains/ultrastructure , Neuronal Calcium-Sensor Proteins/metabolism , Neurons/ultrastructure , Neuropeptides/metabolism , Octoxynol/pharmacology , PC12 Cells , Rats , SNARE Proteins/metabolism , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , beta-Cyclodextrins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...